Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Bill status
signed
all 5 stages cleared
Introduction
Jan 2020
Committee Review
Feb 2021
General Assembly Passage
Jul 2020
Senate Passage
Jun 2021
Signed into Law
Nov 2021
Introduced Jan 14, 2020
Signed Nov 8, 2021
Floor votes · Senate Jun 3, 2021 · General Assembly Jul 30, 2020
How they voted
37–0
Passed · 2 other
Total votes 39
Jun 3, 2021
D
Democratic26
92% Yea
R
Republican13
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
8
Key actions
5
Committee
3
Nov 8, 2021
Signed into law
Approved P.L.2021, c.285.
executive
Jun 3, 2021
Upper · Passed
Passed Senate (Passed Both Houses) (38-0)
upper
Feb 9, 2021
Upper · Passed
Reported out of Senate Committee, 2nd Reading
upper
Aug 3, 2020
Committee
Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
Jul 30, 2020
Lower · Passed
Passed Assembly (74-0-0)
lower
Mar 5, 2020
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Jan 14, 2020
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
4 primary · 2 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about A 277
Scope: NJ
Hi! I can help you understand A 277. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline